Design patterns for automation of marketing authorisations in pharmaceutical industry
This paper reports on experiences of generating COTS components when designing and deploying component based software architecture for automation and interoperation of medicinal product evaluations across different countries in the world. Our generic architectural model renders two sets of software components that are candidates for COTS components. We identify which role such COTS components may play and outline our approach of generating them. We advocate that such COTS components are developed with a specific component platform in mind and must adhere to constraints of our software architecture.